Achieving Immune Tolerance through Hematopoietic Mixed Chimerism in Deceased Donation
Thursday, September 20, 2018 - 14:00 to 15:00
Speaker: David H. Sachs, MD • CUMC & MGH/HMS
Moderator: Sebastian Eriksson Giwa, PhD • Ossium Health and Sylvatica Biotech
After participating in this webinar, the learner will be able to:
- Explain the advantages of tolerance vs. immune suppression.
- Evaluate the overall status of clinical transplant tolerance and the protocols used in trials.
- Identify current limitations to immune tolerance protocols.
- Identify potential solutions through the use of organ and cell preservation technologies.
- Evaluate the protocols in trials and the overall status of clinical transplant tolerance.
Education Category:
Series category:
T3: Timely Topics in Transplantion
Donate
Donate
Career Center
Career Center
Patient Education
Patient Education
Educational Content Disclaimer: The content, information, opinions, and viewpoints contained in educational materials housed on and linked from the AST web site are those of the authors or contributors of such materials. While the AST and its committees take great care to screen the credentials of the contributors and make every attempt to review the contents, AST MAKES NO WARRANTY, EXPRESSED OR IMPLIED, as to the completeness or accuracy of the content contained in the educational materials or on this website. The reader of these materials uses these materials at his or her own risk, and AST shall not be responsible for any errors, omissions, or inaccuracies in these materials, whether arising through negligence, oversight, or otherwise. Reliance on any information appearing on this site is strictly at your own risk. Read the full disclaimer.